Alfredo Fusco

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 169 publications

Potential therapeutic targets and biomarkers in testicular germ cell tumor oncogenesis.

Potential therapeutic targets and biomarkers in testicular germ cell tumor oncogenesis.

Journal: Expert opinion on therapeutic targets

Published: August 21, 2025

Inhibition of HMGA2 Leads to Reduced Cell Proliferation and Increased Apoptosis in Human Embryonal Carcinoma Cell Lines.

Inhibition of HMGA2 Leads to Reduced Cell Proliferation and Increased Apoptosis in Human Embryonal Carcinoma Cell Lines.

Journal: Andrology

Published: July 22, 2025

The Interconnection Between UbcH10, p53, and EGFR in Lung Cancer Cells and Their Involvement in Treatment Response.

The Interconnection Between UbcH10, p53, and EGFR in Lung Cancer Cells and Their Involvement in Treatment Response.

Journal: Genes

Published: January 29, 2025

Passive versus active educational interventions for nevus and melanoma classification: A randomized controlled study.

Passive versus active educational interventions for nevus and melanoma classification: A randomized controlled study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 08, 2024

Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma.

Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma.

Journal: Cell cycle (Georgetown, Tex.)

Published: January 02, 2024

Differential Expression of LncRNA in Bladder Cancer Development.

Differential Expression of LncRNA in Bladder Cancer Development.

Journal: Diagnostics (Basel, Switzerland)

Published: April 19, 2023

The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness.

The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness.

Journal: Cell death discovery

Published: March 28, 2023

Correction to: Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.

Correction to: Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.

Journal: Oncogene

Published: December 21, 2022

Correction: Sepe et al. The Long Non-Coding RNA RP5-1024C24.1 and Its Associated-Gene MPPED2 Are Down-Regulated in Human Thyroid Neoplasias and Act as Tumour Suppressors. Cancers 2018, 10, 146.

Correction: Sepe et al. The Long Non-Coding RNA RP5-1024C24.1 and Its Associated-Gene MPPED2 Are Down-Regulated in Human Thyroid Neoplasias and Act as Tumour Suppressors. Cancers 2018, 10, 146.

Journal: Cancers

Published: December 05, 2022

Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas.

Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas.

Journal: Cancers

Published: April 21, 2022

The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors.

The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors.

Journal: Cell cycle (Georgetown, Tex.)

Published: March 14, 2022

Critical role of the high mobility group A proteins in hematological malignancies.

Critical role of the high mobility group A proteins in hematological malignancies.

Journal: Hematological oncology

Published: August 02, 2021

Showing 1-12 of 169

Last Updated: 09/26/2026